Ms. McDonald Rivet (for herself, Mr. Carter of Georgia, Mr. Menendez, and Mr. James) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1984 to increase oversight of pharmacy benefit management services, and for other purposes.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Prescription Drug Transparency and Affordability Act. H.R. 2450. 119th
Cong., 1st
sess., Introduced in House March 27, 2025. https://www.govinfo.gov/app/details/BILLS-119hr2450ih.
APA
Congress, House of Representatives (2025, March 27). Prescription Drug Transparency and Affordability Act (H.R. 2450 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr2450ih.
MLA
United States, Congress, House of Representatives. Prescription Drug Transparency and Affordability Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr2450ih. 119th Congress, H.R. 2450, Introduced in House 27 Mar. 2025.
Bluebook
H.R.2450 - 119th Congress (2025-2026): Prescription Drug Transparency and Affordability Act, H.R.2450, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119hr2450ih.
